Sanarus Products
Sanarus is dedicated to providing products and procedures that improve the experience for both patient and physician. Our integrated product portfolio offers a complete cryoablation solution for breast care, from diagnosis to treatment to recovery and follow-up. These products include:
- The ImarC™ Tissue Marker System
- The Visica 2™ Treatment System
Diagnosis
The ImarC™ Marker System provides permanent visibility of the biopsy site under a variety of imaging modalities, including X-ray, ultrasound and MRI.
On October 20, 2011, Scion Medical Technologies, LLC (Scion) acquired the Cassi II line of breast biopsy products from Sanarus. For information and ordering Cassi product, please visit www.scionmedtech.com or call 888-582-6211. Sanarus no longer sells Cassi II products.
Treatment
The Visica 2™ Treatment System offers a minimally invasive treatment option for fibroadenomas with complete ablation and no reported regrowth in over 2,000 cases. The in-office procedure has few complications, excellent cosmesis and patient satisfaction with minimal pain and recovery time.
Recovery and Follow up
Initial patient recovery from the Visica 2 treatment procedure takes 4-6 hours. Depending on the size of the lesion, the patient will usually feel a lump for a number of months as the body reabsorbs the abnormal tissue. With a fibroadenoma smaller than 2 cm, complete resolution can be expected in 66% of patients at 6 months; 75% of patients at 12 months.1 All patients who undergo the cryoablation procedure should have clinical follow-up by the treating physician.
